Nervous when you see an epidermic needle, even if the shot can save your life? A significant link between behavioral stress and the effectiveness of vaccines has been demonstrated for the first time in mouse models by Tel Aviv University (TAU) researchers.
They found that acute stress in mice nine to 12 days after COVID-19 vaccination increases antibody response to the vaccine by 70% compared to the unstressed control group. This, however, comes at the price of reduced antibody breadth (the number of antigens to which an individual had antibody titers above the threshold antibody concentrations) that results in diminished protection against the pathogen’s variants.
“For the first time, we examined the effects of behavioral stress on vaccine effectiveness,” they added. “We found dramatic impact of this stress – on both the vaccine’s effectiveness and its mode of operation.”
The study was carried out and led by doctoral student Noam Ben-Shalom in the lab of Dr. Natalia Freund at TAU’s Faculty of Medicine and doctoral student Elad Sandbank from the neuroimmunology lab of Prof. Shamgar Ben-Eliyahu at the School of Psychological Sciences and the Sagol School of Neuroscience.
The paper was published in the leading scientific journal Brain, Behavior, and Immunity under the title “β2-adrenergic signaling promotes higher-affinity B cells and antibodies.”
Stress impedes vaccine effects
Freund explained that “In this study, we examined, for the first time, the correlation between stress and the body’s ability to develop an immune response following vaccination. The prevailing assumption is that the effectiveness of a vaccine is determined mainly by its own quality. However, over the years, professional literature has reported influences of other factors as well, such as the age, genetics, and microbiome of the outcomes of vaccination. Our study was the first to investigate the possible effects of acute stress. We found that this mental state has a dramatic impact – not only on the vaccine’s effectiveness but also on how it works.”
Acute stress is a mental state caused by an immediate threat – either real or imagined – involving the secretion of adrenaline and stimulation. Freund and her colleagues vaccinated mice with two different vaccines – the model protein ovalbumin (a protein used as an antigen in vaccination experiments that comes from chicken egg whites) and a fragment of the SARS-CoV-2 spike protein also used in the COVID-19 vaccine.
Nine days later, just as the adaptive immunity became active and the production of antibodies began, the mice were subjected to a widely used behavioral model simulating acute stress. Two-and-a-half weeks after exposure to the stress caused by the vaccination, the level of antibodies in the blood of vaccinated animals that had experienced stress was 70% higher compared to the control group. This phenomenon was observed in animals vaccinated with either type of vaccine.
At the same time, the researchers discovered that the immune system of the animals that had experienced stress was not cross-reactive to variants of the protein used in the vaccine. In other words, following stress, the immune system was focused entirely on the original vaccine, showing no response to proteins that were only slightly different – such as variants of concern (alpha, beta, gamma, and delta variants) of SARS-CoV-2.
At first, they were surprised to find out that the response to the vaccine was much more effective in animals that had experienced stress, Freud recalled.
“We would have assumed just the opposite – that stressful situations would have a negative impact on the immune system. But with both types of vaccines, we saw a stronger immune response after stress, both in the blood and in B cells (the lymphocytes that produce antibodies) derived from the spleen and lymph nodes of the immunized mice. The enhancement of the antibodies’ activity following stress was mediated by the cellular receptor that identifies adrenaline – the beta2 adrenergic receptor.”
When the team blocked this receptor, either pharmacologically or by means of genetic engineering, the effects of stress were completely eliminated. On the other hand, to their great surprise, the breadth of the immune response generated by the vaccine was reduced by about 50% following stress.
“In general, the purpose of vaccination is not only protection against a specific pathogen but also creating a long-lasting immunological memory for protection against future mutations of that pathogen. In this sense, the vaccines appeared to lose much of their effectiveness after exposure to stress,” Freud continued.
According to the researchers, this is in fact a classical “fight or flight” response, but this time shown at the molecular level. “During stress, the immune system produces large quantities of antibodies and stronger antibodies, to address the immediate infection, and this large energetic investment in the here and now comes at the expense of future immunological memory.”
She added that “in the second part of the study, we wanted to test whether humans also display the post-stress immune impairment observed in vaccinated mice. We cultured B cells from the blood of people who had contracted COVID-19 in the first wave. We then induced stress in these cultures using an adrenaline-like substance that stimulates the beta2 adrenergic receptor, which was identified by us in the first part of the study as a mediator of the response to stress in cells that produce antibodies in mice. B cells express a very high level of these receptors, but until now the receptors’ role in producing antibodies was not known. In fact, it was unclear why these cells need the ability to respond to adrenaline. We discovered that just like in mice, human cells also exhibit a zero-sum game between the intensity and breadth of the immune response.”
When the adrenaline receptor is activated during stress, the whole immune system is stimulated, generating antibodies that are 100-fold stronger than antibodies produced in cells that had not undergone stress. But here too, the response was narrower; the diversity of antibodies was reduced by 20% to 100% depending on the individual from whom the cells were taken.
“From the evolutionary perspective,” she concluded, “stress can be caused by different factors. We tend to think of mental stress, but physical illness also causes a form of stress. When the body contracts a virus or bacteria, it experiences stress and signals to the immune system that the top priority is getting rid of the pathogen, while investing energy in long-term immunological memory is a second priority. So stress nine to 12 days after vaccination, at the time when B cells are generating high-affinity antibodies, enhances short-term immunity and damages long-term memory.”